Brief: UroGen Pharma Says Molly Henderson Tendered Her Resignation As CFO Effective March 25

UroGen Pharma

21/03/2022 12:18

March 21 (Reuters) - Urogen Pharma Ltd  UR8.F :
    * UROGEN PHARMA LTD -  ON MARCH 17, 2022, MOLLY HENDERSON
TENDERED
HER RESIGNATION AS CO’S CFO, EFFECTIVE MARCH 25, 2022 - SEC
FILING
    * UROGEN PHARMA LTD -  EFFECTIVE AS OF MARCH 25, 2022, CO
APPOINTED DONG KIM AS CFO, REPLACING HENDERSON IN SUCH
CAPACITIES

Further company coverage:  UR8.F 

 ((Reuters.Briefs@thomsonreuters.com;))